| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | CEO Of Specialty Renal Product | President And CEO
2 companies
Evans Daron is a CFO at Rezolute, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 20 buys and 0 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 50,000 | $1.93 | $96,345.00 | +70.5% | +194.2% | +102.6% | |
| Feb 16, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 50,900 | $1.31 | $66,741.34 | +175.5% | +89.6% | +241.5% | |
| Mar 12, 2020 | NEPH Nephros Inc | President And CEO | Buy | 2,500 | $6.65 | $16,625.00 | +1.9% | - | - | |
| Mar 5, 2020 | NEPH Nephros Inc | President And CEO | Buy | 2,500 | $8.44 | $21,109.00 | +1.9% | - | - | |
| Nov 18, 2019 | NEPH Nephros Inc | President And CEO | Buy | 1,000 | $8.35 | $8,350.00 | +0.8% | - | - | |
| Aug 22, 2019 | NEPH Nephros Inc | President And CEO | Buy | 2,000 | $6.92 | $13,845.40 | +1.7% | - | - | |
| Jun 14, 2019 | NEPH Nephros Inc | President And CEO | Buy | 43,172 | $0.60 | $25,760.69 | +3.7% | - | - | |
| Apr 10, 2018 | NEPH Nephros Inc | President And CEO | Buy | 79,000 | $0.45 | $35,550.00 | +75.4% | - | - | |
| Sep 6, 2017 | NEPH Nephros Inc | President And CEO | Buy | 29,580 | $0.24 | $7,189.30 | +2.2% | - | - | |
| Aug 22, 2017 | NEPH Nephros Inc | President And CEO | Buy | 4,000 | $0.25 | $1,000.00 | +4.0% | - | - |